Show simple item record

dc.contributor.authorSelva, Erica Marie
dc.contributor.authorRaden, David L.
dc.contributor.authorDavis, Roger J.
dc.date2022-08-11T08:10:04.000
dc.date.accessioned2022-08-23T16:54:24Z
dc.date.available2022-08-23T16:54:24Z
dc.date.issued1993-01-25
dc.date.submitted2008-08-15
dc.identifier.citationJ Biol Chem. 1993 Jan 25;268(3):2250-4.
dc.identifier.issn0021-9258 (Print)
dc.identifier.pmid7678418
dc.identifier.urihttp://hdl.handle.net/20.500.14038/42493
dc.description.abstractMutation of the epidermal growth factor receptor (EGF-R) within the ATP binding subdomain results in a receptor that lacks tyrosine kinase activity and is defective in signal transduction. However, this kinase-negative EGF-R is able to activate MAP kinase (Campos-Gonzalez, R., and Glenny, J. R. (1992) J. Biol. Chem. 267, 14535-14538). This observation suggests that signal initiation by the EGF-R can occur by a mechanism that is independent of the receptor tyrosine kinase activity. Here, we report that the kinase-negative EGF-R is phosphorylated on tyrosine in EGF-treated cells. The mechanism of tyrosine phosphorylation can be accounted for by the action of EGF to stimulate a protein kinase activity that is associated with the kinase-negative EGF-R. This protein kinase activity is not intrinsic to the receptor and can be separated from the EGF-R by incubation with 0.5 M NaCl. MAP kinase activation by the kinase-negative EGF-R may therefore occur by a mechanism that requires a receptor-associated tyrosine kinase. Thus, it is unnecessary to propose a novel kinase-independent mechanism of signal initiation to account for MAP kinase activation by the kinase-negative EGF-R.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=7678418&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://www.jbc.org/content/268/3/2250.long
dc.subjectAmino Acid Sequence
dc.subjectAnimals
dc.subjectCHO Cells
dc.subjectCalcium-Calmodulin-Dependent Protein Kinases
dc.subjectCricetinae
dc.subjectEnzyme Activation
dc.subjectEpidermal Growth Factor
dc.subjectGene Expression
dc.subjectHumans
dc.subjectMitogens
dc.subjectMolecular Sequence Data
dc.subjectMutagenesis
dc.subjectPhosphorylation
dc.subjectPhosphotyrosine
dc.subjectProtein Kinases
dc.subjectProtein-Tyrosine Kinases
dc.subjectReceptor, Epidermal Growth Factor
dc.subjectSignal Transduction
dc.subjectTyrosine
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleMitogen-activated protein kinase stimulation by a tyrosine kinase-negative epidermal growth factor receptor
dc.typeJournal Article
dc.source.journaltitleThe Journal of biological chemistry
dc.source.volume268
dc.source.issue3
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/837
dc.identifier.contextkey579724
html.description.abstract<p>Mutation of the epidermal growth factor receptor (EGF-R) within the ATP binding subdomain results in a receptor that lacks tyrosine kinase activity and is defective in signal transduction. However, this kinase-negative EGF-R is able to activate MAP kinase (Campos-Gonzalez, R., and Glenny, J. R. (1992) J. Biol. Chem. 267, 14535-14538). This observation suggests that signal initiation by the EGF-R can occur by a mechanism that is independent of the receptor tyrosine kinase activity. Here, we report that the kinase-negative EGF-R is phosphorylated on tyrosine in EGF-treated cells. The mechanism of tyrosine phosphorylation can be accounted for by the action of EGF to stimulate a protein kinase activity that is associated with the kinase-negative EGF-R. This protein kinase activity is not intrinsic to the receptor and can be separated from the EGF-R by incubation with 0.5 M NaCl. MAP kinase activation by the kinase-negative EGF-R may therefore occur by a mechanism that requires a receptor-associated tyrosine kinase. Thus, it is unnecessary to propose a novel kinase-independent mechanism of signal initiation to account for MAP kinase activation by the kinase-negative EGF-R.</p>
dc.identifier.submissionpathoapubs/837
dc.contributor.departmentProgram in Molecular Medicine
dc.contributor.departmentDepartment of Biochemistry and Molecular Biology
dc.source.pages2250-4


This item appears in the following Collection(s)

Show simple item record